The impact of extramedullary disease at presentation on the outcome of myeloma patients treated with high-dose therapy and autologous stem cell transplantation

被引：0
|
作者：
Pokrovskaya, O. [1 ]
Mandeleeva, L. [1 ]
Galayko, M. [1 ]
Urnova, E. [1 ]
Nareyko, M. [1 ]
Kovrigina, A. [1 ]
Kostina, I. [1 ]
Varlamova, E. [1 ]
Parovichnikova, E. [1 ]
Savchenko, V. [1 ]
机构：
[1] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [1] Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome
    Kumar, L.
    Gogi, R.
    Patel, A. K.
    Mookerjee, A.
    Sahoo, R. K.
    Malik, P. S.
    Sharma, A.
    Thulkar, S.
    Kumar, R.
    Biswas, A.
    Sharma, O. D.
    Gupta, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 (10) : 1473 - 1475
  • [2] Multiple myeloma with extramedullary disease: impact of autologous stem cell transplantation on outcome
    L Kumar
    R Gogi
    A K Patel
    A Mookerjee
    R K Sahoo
    P S Malik
    A Sharma
    S Thulkar
    R Kumar
    A Biswas
    O D Sharma
    R Gupta
    Bone Marrow Transplantation, 2017, 52 : 1473 - 1475
  • [3] Progression of bone disease in multiple myeloma patients treated with high dose therapy and autologous stem cell transplantation.
    Thornton, CO
    Ballester, O
    Greenfield, GB
    BLOOD, 1996, 88 (10) : 1912 - 1912
  • [4] High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma
    Koh, LP
    Linn, YC
    Teoh, G
    Goh, YT
    Tan, PHC
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2002, 31 (06) : 731 - 737
  • [5] EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION: CLINICAL IMPACT IN DIAGNOSIS, TREATMENT AND OUTCOME
    Roque, A.
    Pinto, A. L.
    Cortesao, E.
    Espadana, A. I.
    Sarmento-Ribeiro, A. B.
    Geraldes, C.
    Ribeiro, L.
    HAEMATOLOGICA, 2017, 102 : 531 - 532
  • [6] The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
    Pham, R. N.
    Gooley, T. A.
    Keeney, G. E.
    Press, O. W.
    Pagel, J. M.
    Greisman, H. A.
    Bensinger, W. I.
    Holmberg, L. A.
    Petersdorf, S. H.
    Maloney, D. G.
    Gopal, A. K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (11) : 1039 - 1044
  • [7] The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma
    R N Pham
    T A Gooley
    G E Keeney
    O W Press
    J M Pagel
    H A Greisman
    W I Bensinger
    L A Holmberg
    S H Petersdorf
    D G Maloney
    A K Gopal
    Bone Marrow Transplantation, 2007, 40 : 1039 - 1044
  • [8] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [9] A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently
    Kazmi, Syed
    Lu, Gary
    Shah, Nina
    Bashir, Qaiser
    Parmar, Simrit
    Orlowski, Robert Z.
    Shah, Jatin J.
    Hosing, Chitra M.
    Popat, Uday
    Dinh, Yvonne T.
    Qureshi, Sofia
    Rondon, Gabriela
    Giralt, Sergio
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BLOOD, 2011, 118 (21) : 1778 - 1778
  • [10] Rituximab associated cardiotoxicity in patients treated with high-dose therapy and autologous stem cell transplantation.
    Ballester, OF
    Fang, T
    Wilcox, P
    Tan, B
    Payne, M
    Bruno, G
    Braun, B
    BLOOD, 1999, 94 (10) : 354B - 354B
12345